Report Cover

United States Atovaquone and Proguanil Market Report & Forecast 2021-2027


United States Atovaquone and Proguanil Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
United States Atovaquone and Proguanil Market Segment Percentages, By Type, 2020 (%)
    250 mg/100 mg
    62.5mg/25mg

United States Atovaquone and Proguanil Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
United States Atovaquone and Proguanil Market Segment Percentages, By Application, 2020 (%)
    Adult
    Paediatric

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Atovaquone and Proguanil revenues in United States market, 2016-2021 (Estimated), ($ millions)
Key companies Atovaquone and Proguanil revenues share in United States market, 2020 (%)
Key companies Atovaquone and Proguanil sales in United States market, 2016-2021 (Estimated), (K Units)
Key companies Atovaquone and Proguanil sales share in United States market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
    GSK
    Glenmark
    Mylan Pharmaceuticals
    Hetero
1 Introduction to Research & Analysis Reports
    1.1 Atovaquone and Proguanil Market Definition
    1.2 Market Segments
        1.2.1 Segment by Type
        1.2.2 Segment by Application
    1.3 United States Atovaquone and Proguanil Market Overview
    1.4 Methodology & Sources of Information
        1.4.1 Research Methodology
        1.4.2 Research Process
        1.4.3 Base Year

2 United States Atovaquone and Proguanil Overall Market Size
    2.1 United States Atovaquone and Proguanil Market Size: 2021 VS 2027
    2.2 United States Atovaquone and Proguanil Revenue, Prospects & Forecasts: 2016-2027
    2.3 United States Atovaquone and Proguanil Sales: 2016-2027

3 Company Landscape
    3.1 Top Atovaquone and Proguanil Players in United States Market
    3.2 Top United States Atovaquone and Proguanil Companies Ranked by Revenue
    3.3 United States Atovaquone and Proguanil Revenue by Companies
    3.4 United States Atovaquone and Proguanil Sales by Companies
    3.5 United States Atovaquone and Proguanil Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Atovaquone and Proguanil Companies in United States Market, by Revenue in 2020
    3.7 Manufacturers Atovaquone and Proguanil Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Atovaquone and Proguanil Players in United States Market
        3.8.1 List of Tier 1 Atovaquone and Proguanil Companies in United States
        3.8.2 List of Tier 2 and Tier 3 Atovaquone and Proguanil Companies in United States

4 Sights by Type
    4.1 Overview
        4.1.1 By Type - United States Atovaquone and Proguanil Market Size Markets, 2021 & 2027
        4.1.2 250 mg/100 mg
        4.1.3 62.5mg/25mg
    4.2 By Type - United States Atovaquone and Proguanil Revenue & Forecasts
        4.2.1 By Type - United States Atovaquone and Proguanil Revenue, 2016-2021
        4.2.2 By Type - United States Atovaquone and Proguanil Revenue, 2022-2027
        4.2.3 By Type - United States Atovaquone and Proguanil Revenue Market Share, 2016-2027
    4.3 By Type - United States Atovaquone and Proguanil Sales & Forecasts
        4.3.1 By Type - United States Atovaquone and Proguanil Sales, 2016-2021
        4.3.2 By Type - United States Atovaquone and Proguanil Sales, 2022-2027
        4.3.3 By Type - United States Atovaquone and Proguanil Sales Market Share, 2016-2027
    4.4 By Type - United States Atovaquone and Proguanil Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
    5.1 Overview
        5.1.1 By Application - United States Atovaquone and Proguanil Market Size, 2021 & 2027
        5.1.2 Adult
        5.1.3 Paediatric
    5.2 By Application - United States Atovaquone and Proguanil Revenue & Forecasts
        5.2.1 By Application - United States Atovaquone and Proguanil Revenue, 2016-2021
        5.2.2 By Application - United States Atovaquone and Proguanil Revenue, 2022-2027
        5.2.3 By Application - United States Atovaquone and Proguanil Revenue Market Share, 2016-2027
    5.3 By Application - United States Atovaquone and Proguanil Sales & Forecasts
        5.3.1 By Application - United States Atovaquone and Proguanil Sales, 2016-2021
        5.3.2 By Application - United States Atovaquone and Proguanil Sales, 2022-2027
        5.3.3 By Application - United States Atovaquone and Proguanil Sales Market Share, 2016-2027
    5.4 By Application - United States Atovaquone and Proguanil Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
    6.1 GSK
        6.1.1 GSK Corporation Information
        6.1.2 GSK Overview
        6.1.3 GSK Atovaquone and Proguanil Sales and Revenue in United States Market (2016-2021)
        6.1.4 GSK Atovaquone and Proguanil Product Description
        6.1.5 GSK Recent Developments
    6.2 Glenmark
        6.2.1 Glenmark Corporation Information
        6.2.2 Glenmark Overview
        6.2.3 Glenmark Atovaquone and Proguanil Sales and Revenue in United States Market (2016-2021)
        6.2.4 Glenmark Atovaquone and Proguanil Product Description
        6.2.5 Glenmark Recent Developments
    6.3 Mylan Pharmaceuticals
        6.3.1 Mylan Pharmaceuticals Corporation Information
        6.3.2 Mylan Pharmaceuticals Overview
        6.3.3 Mylan Pharmaceuticals Atovaquone and Proguanil Sales and Revenue in United States Market (2016-2021)
        6.3.4 Mylan Pharmaceuticals Atovaquone and Proguanil Product Description
        6.3.5 Mylan Pharmaceuticals Recent Developments
    6.4 Hetero
        6.4.1 Hetero Corporation Information
        6.4.2 Hetero Overview
        6.4.3 Hetero Atovaquone and Proguanil Sales and Revenue in United States Market (2016-2021)
        6.4.4 Hetero Atovaquone and Proguanil Product Description
        6.4.5 Hetero Recent Developments

7 United States Atovaquone and Proguanil Production Capacity, Analysis
    7.1 United States Atovaquone and Proguanil Production Capacity, 2016-2027
    7.2 Atovaquone and Proguanil Production Capacity of Key Manufacturers in United States Market

8 Key Market Trends, Opportunity, Drivers and Restraints
    8.1 Market Opportunities & Trends
    8.2 Market Drivers
    8.3 Market Restraints

9 Atovaquone and Proguanil Supply Chain Analysis
    9.1 Atovaquone and Proguanil Industry Value Chain
    9.2 Atovaquone and Proguanil Upstream Market
    9.3 Atovaquone and Proguanil Downstream and Clients
    9.4 Marketing Channels Analysis
        9.4.1 Marketing Channels
        9.4.2 Atovaquone and Proguanil Distributors and Sales Agents in United States Market

10 Conclusion
11 Appendix
    11.1 Note
    11.2 Examples of Clients
    11.3 Author Details
    11.4 Disclaimer

List of Tables Table 1. Key Players of Atovaquone and Proguanil in United States Market Table 2. Top Atovaquone and Proguanil Players in United States Market, Ranking by Revenue (2019) Table 3. United States Atovaquone and Proguanil Revenue by Companies, (US$, Mn), 2016-2021 Table 4. United States Atovaquone and Proguanil Revenue Share by Companies, 2016-2021 Table 5. United States Atovaquone and Proguanil Sales by Companies, (K Units), 2016-2021 Table 6. United States Atovaquone and Proguanil Sales Share by Companies, 2016-2021 Table 7. Key Manufacturers Atovaquone and Proguanil Price (2016-2021) & (USD/Unit) Table 8. Manufacturers Atovaquone and Proguanil Product Type Table 9. List of Tier 1 Atovaquone and Proguanil Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Atovaquone and Proguanil Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. Major Manufacturers of 250 mg/100 mg Table 12. Major Manufacturers of 62.5mg/25mg Table 13. By Type - United States Atovaquone and Proguanil Revenue, (US$, Mn), 2021 & 2027 Table 14. By Type - United States Atovaquone and Proguanil Revenue (US$, Mn), 2016-2021 Table 15. By Type - United States Atovaquone and Proguanil Revenue (US$, Mn), 2022-2027 Table 16. By Type - United States Atovaquone and Proguanil Sales (K Units), 2016-2021 Table 17. By Type - United States Atovaquone and Proguanil Sales (K Units), 2022-2027 Table 18. By Application - United States Atovaquone and Proguanil Revenue, (US$, Mn), 2021 VS 2027 Table 19. By Application - United States Atovaquone and Proguanil Revenue (US$, Mn), 2016-2021 Table 20. By Application - United States Atovaquone and Proguanil Revenue (US$, Mn), 2022-2027 Table 21. By Application - United States Atovaquone and Proguanil Sales (K Units), 2016-2021 Table 22. By Application - United States Atovaquone and Proguanil Sales (K Units), 2022-2027 Table 23. GSK Corporation Information Table 24. GSK Description and Major Businesses Table 25. GSK Atovaquone and Proguanil Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021) Table 26. GSK Atovaquone and Proguanil Product Table 27. GSK Recent Developments Table 28. Glenmark Corporation Information Table 29. Glenmark Description and Major Businesses Table 30. Glenmark Atovaquone and Proguanil Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021) Table 31. Glenmark Atovaquone and Proguanil Product Table 32. Glenmark Recent Developments Table 33. Mylan Pharmaceuticals Corporation Information Table 34. Mylan Pharmaceuticals Description and Major Businesses Table 35. Mylan Pharmaceuticals Atovaquone and Proguanil Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021) Table 36. Mylan Pharmaceuticals Atovaquone and Proguanil Product Table 37. Mylan Pharmaceuticals Recent Developments Table 38. Hetero Corporation Information Table 39. Hetero Description and Major Businesses Table 40. Hetero Atovaquone and Proguanil Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021) Table 41. Hetero Atovaquone and Proguanil Product Table 42. Hetero Recent Developments Table 43. Atovaquone and Proguanil Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units) Table 44. United States Atovaquone and Proguanil Capacity Market Share of Key Manufacturers, 2019-2021 Table 45. Atovaquone and Proguanil Market Opportunities & Trends in United States Market Table 46. Atovaquone and Proguanil Market Drivers in United States Market Table 47. Atovaquone and Proguanil Market Restraints in United States Market Table 48. Atovaquone and Proguanil Raw Materials Table 49. Atovaquone and Proguanil Raw Materials Suppliers in United States Market Table 50. Typical Atovaquone and Proguanil Downstream Table 51. Atovaquone and Proguanil Downstream Clients in United States Market Table 52. Atovaquone and Proguanil Distributors and Sales Agents in United States Market List of Figures Figure 1. Atovaquone and Proguanil Product Picture Figure 2. Atovaquone and Proguanil Segment by Type Figure 3. Atovaquone and Proguanil Segment by Application Figure 4. United States Atovaquone and Proguanil Market Overview: 2020 Figure 5. United States Atovaquone and Proguanil Market Size: 2021 VS 2027 (US$, Mn) Figure 6. United States Atovaquone and Proguanil Revenue, 2016-2027 (US$, Mn) Figure 7. Atovaquone and Proguanil Sales in United States Market: 2016-2027 (K Units) Figure 8. The Top 3 and 5 Players Market Share by Atovaquone and Proguanil Revenue in 2020 Figure 9. 250 mg/100 mg Product Picture Figure 10. 62.5mg/25mg Product Picture Figure 11. By Type - United States Atovaquone and Proguanil Sales Market Share, 2016-2027 Figure 12. By Type - United States Atovaquone and Proguanil Revenue Market Share, 2016-2027 Figure 13. By Type - United States Atovaquone and Proguanil Price (USD/Unit), 2016-2027 Figure 14. Adult Figure 15. Paediatric Figure 16. By Application - United States Atovaquone and Proguanil Sales Market Share, 2016-2027 Figure 17. By Application - United States Atovaquone and Proguanil Revenue Market Share, 2016-2027 Figure 18. By Application - United States Atovaquone and Proguanil Price (USD/Unit), 2016-2027 Figure 19. GSK Atovaquone and Proguanil Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 20. Glenmark Atovaquone and Proguanil Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 21. Mylan Pharmaceuticals Atovaquone and Proguanil Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 22. Hetero Atovaquone and Proguanil Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 23. United States Atovaquone and Proguanil Production Capacity (K Units), 2016-2027 Figure 24. Atovaquone and Proguanil Industry Value Chain Figure 25. Marketing Channels

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us